Unruptured Intracranial Aneurysms- Pathogenesis and Individualized Management.
CONCLUSION: Patients with unruptured IA should be massessed and managed individually. It is also important that risk factors should be treated, if present. Eligible patients are currently being recruited for a phase III clinical trial on the efficacy of blood pressure reduction combined with acetylsalicylic acid intake to counteract inflammatory processes in the arterial wall.
PMID: 32449895 [PubMed - as supplied by publisher]
Source: Deutsches Arzteblatt International - Category: General Medicine Tags: Dtsch Arztebl Int Source Type: research
More News: Alcoholism | Clinical Trials | Databases & Libraries | General Medicine | Germany Health | Hypertension | Smokers | Statistics | Subarachnoid Hemorrhage